Contact Lenses/Eye Wear News

Performance Vision Technologies has launched Altius advanced performance-tinted contact lenses, the second generation to Nike MaxSight, in the U.S. and select international markets.

Research into effective treatments for myopic progression expands beyond contact lenses and involves atropine, red light therapy and spectacle lenses, as Healio has reported throughout 2023.

For eye care providers who practice evidence-based medicine, one guiding principle is the reliability of a treatment’s effectiveness, which goes far beyond intuition, experience and training and instead depends on sound, valid science.

Azura Ophthalmics announced positive topline results from its phase 2 study of AZR-MD-001 in patients with contact lens discomfort and signs of meibomian gland dysfunction.

This year, we looked ahead to the future of contact lenses, with news stories detailing advancements in virtual reality, legislation to ban prescription robocalls and technology that measures IOP almost as well as the Goldmann tonometer.

Developments in spectacle lenses over the past year have revealed their efficacy beyond vision correction.

CooperVision has created a multidisciplinary initiative that will expand access to myopia treatment for underserved children in the United States through partnerships with optometry schools, the company announced in a press release.

Azalea Vision announced the first on-eye test of its ALMA proprietary smart contact lens, which is designed to offer a nonsurgical solution for patients with keratoconus, corneal irregularities, photophobia and presbyopia.

We are fortunate today that not only are there new and better forms of corneal transplants, but we also do not have to refer keratoconus patients for a transplant nearly as often.

Today’s presbyopes lead increasingly digital lifestyles, with extensive attention to screens, which research shows can cause decreased and incomplete blinking, tear film instability and lead to the development of dry eye disease.